Drugs / WD-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06675513 | May 2025 → Dec 2027 | colorectal cancer | Wondercel Biotech (ShenZhen) | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WD-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06675513 ↗ |
| Modality | Cell therapy | “GCC-targeting CAR-T therapy (WD-01)” NCT06675513 ↗ |